{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:06:05Z","timestamp":1740107165619,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Health Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The primary objective of this study was to investigate the association between disease activity and serum and salivary procalcitonin (Pct) levels in patients with Beh\u00e7et\u2019s disease (BD). The study included patients diagnosed with BD and age-matched healthy volunteers (<jats:italic>N<\/jats:italic>: 48, <jats:italic>N<\/jats:italic>: 32). Serum and salivary Pct levels were quantified using enzyme-linked immunosorbent assay (ELISA) in the laboratories of Diskapi Yildirim Beyazit Training and Research Hospital. No significant disparity was observed in serum and salivary Pct levels between the patient and control groups (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05). Furthermore, there was no noteworthy correlation between disease activity and serum and salivary Pct values (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05). However, the serum Pct level in patients with active oral ulcers was significantly elevated compared to those without active oral ulcers (<jats:italic>p<\/jats:italic>: 0.003). Serum Pct emerges as a valuable marker for monitoring oral aphthous ulcer attacks within the patient population.<\/jats:p>","DOI":"10.1007\/s00403-023-02805-0","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T15:03:49Z","timestamp":1705590229000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Can the mucosal attacks of Beh\u00e7et\u2019s disease be predicted?"],"prefix":"10.1007","volume":"316","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7310-8635","authenticated-orcid":false,"given":"Selda Pelin","family":"Kartal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9884-1531","authenticated-orcid":false,"given":"Gamze","family":"Ta\u015f-Aygar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8147-3402","authenticated-orcid":false,"given":"\u00dcmm\u00fc G\u00fcl","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1846-9248","authenticated-orcid":false,"given":"Ali","family":"Yal\u00e7\u0131nda\u011f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1914-2175","authenticated-orcid":false,"given":"M\u00fczeyyen","family":"G\u00f6n\u00fcl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"issue":"3","key":"2805_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/mec.13536.Application","volume":"41","author":"G Hatemi","year":"2014","unstructured":"Hatemi G, Merkel PA, Hamuryudan V, Boers M, Direskeneli H, Aydin SZ, Yaz\u0131c\u0131 H (2014) Outcome measures used in clinical trials for Beh\u00e7et syndrome: a systematic review. J Rheumatol 41(3):599\u2013612. https:\/\/doi.org\/10.1111\/mec.13536.Application","journal-title":"J Rheumatol"},{"issue":"2","key":"2805_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.5152\/balkanmedj.2013.7932","volume":"30","author":"V Erdem","year":"2013","unstructured":"Erdem V, Yildiz M, Erdem T (2013) The evaluation of saliva flow rate, pH, buffer capacity, microbiological content and indice of decayed, missing and filled teeth in beh\u00e7et\u2019s patients. Balkan Med J 30(2):211\u2013214. https:\/\/doi.org\/10.5152\/balkanmedj.2013.7932","journal-title":"Balkan Med J"},{"issue":"1","key":"2805_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3402\/jom.v7.27150","volume":"7","author":"N Seoudi","year":"2015","unstructured":"Seoudi N, Bergmeier LA, Drobniewski F, Paster B, Fortune F (2015) The oral mucosal and salivary microbial community of Beh\u00e7et\u2019s syndrome and recurrent aphthous stomatitis. J Oral Microbiol 7(1):1\u20139. https:\/\/doi.org\/10.3402\/jom.v7.27150","journal-title":"J Oral Microbiol"},{"issue":"1","key":"2805_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/COPD.S16070","volume":"6","author":"A Lacoma","year":"2011","unstructured":"Lacoma A, Prat C, Andreo F et al (2011) Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease. Int J COPD 6(1):157\u2013169. https:\/\/doi.org\/10.2147\/COPD.S16070","journal-title":"Int J COPD"},{"issue":"6","key":"2805_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11926-010-0132-z","volume":"12","author":"Y Yazici","year":"2010","unstructured":"Yazici Y, Yurdakul S, Yazici H (2010) Beh\u00e7et\u2019s syndrome. Curr Rheumatol Rep 12(6):429\u2013435. https:\/\/doi.org\/10.1007\/s11926-010-0132-z","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"2805_CR6","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s13238-018-0548-1","volume":"9","author":"L Gao","year":"2018","unstructured":"Gao L, Xu T, Huang G, Jiang S, Gu Y, Chen F (2018) Oral microbiomes: more and more importance in oral cavity and whole body. Protein Cell 9(5):488\u2013500. https:\/\/doi.org\/10.1007\/s13238-018-0548-1","journal-title":"Protein Cell"},{"key":"2805_CR7","doi-asserted-by":"crossref","unstructured":"Saadoun D, Wechsler B (2012) Beh\u00e7et\u2019s disease. Published online, 5\u201310","DOI":"10.1186\/1750-1172-7-20"},{"key":"2805_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1155\/2011\/681956","volume":"2011","author":"F Kaneko","year":"2011","unstructured":"Kaneko F, Togashi A, Saito S et al (2011) Beh\u00e7et\u2019s disease (adamantiades-Beh\u00e7et\u2019s disease). Clin Dev Immunol 2011:11\u201313. https:\/\/doi.org\/10.1155\/2011\/681956","journal-title":"Clin Dev Immunol"},{"issue":"3","key":"2805_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-4632.2009.03905.x","volume":"48","author":"SPK Durmazlar","year":"2009","unstructured":"Durmazlar SPK, Ulkar GB, Eskioglu F, Tatlican S, Mert A, Akgul A (2009) Significance of serum interleukin-8 levels in patients with Behcet\u2019s disease: high levels may indicate vascular involvement. Int J Dermatol 48(3):259\u2013264. https:\/\/doi.org\/10.1111\/j.1365-4632.2009.03905.x","journal-title":"Int J Dermatol"},{"key":"2805_CR10","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.ijantimicag.2015.10.012","volume":"46","author":"N Br\u00e9chot","year":"2015","unstructured":"Br\u00e9chot N, H\u00e9kimian G, Chastre J, Luyt CE (2015) Procalcitonin to guide antibiotic therapy in the ICU. Int J Antimicrob Agents 46:S19\u2013S24. https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.10.012","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"2805_CR11","doi-asserted-by":"publisher","first-page":"612","DOI":"10.6061\/clinics\/2015(09)03","volume":"70","author":"X Dai","year":"2015","unstructured":"Dai X, Fu C, Wang C et al (2015) The impact of tracheotomy on levels of procalcitonin in patients without sepsis: a prospective study. Clinics 70(9):612\u2013617. https:\/\/doi.org\/10.6061\/clinics\/2015(09)03","journal-title":"Clinics"},{"issue":"4","key":"2805_CR12","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3904\/kjim.2015.142","volume":"32","author":"CS Lee","year":"2017","unstructured":"Lee CS, Hwang JH, Lee JM, Lee JH (2017) The clinical usefulness of serum procalcitonin level in patients with scrub typhus. Korean J Intern Med 32(4):761\u2013763. https:\/\/doi.org\/10.3904\/kjim.2015.142","journal-title":"Korean J Intern Med"},{"issue":"5","key":"2805_CR13","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1128\/JCM.01348-09","volume":"48","author":"R Bellmann-Weiler","year":"2010","unstructured":"Bellmann-Weiler R, Ausserwinkler M, Kurz K, Theurl I, Weiss G (2010) Clinical potential of C-reactive protein and procalcitonin serum concentrations to guide differential diagnosis and clinical management of pneumococcal and Legionella pneumonia. J Clin Microbiol 48(5):1915\u20131917. https:\/\/doi.org\/10.1128\/JCM.01348-09","journal-title":"J Clin Microbiol"},{"issue":"3","key":"2805_CR14","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1468-3083.2004.00907.x","volume":"18","author":"B Adam","year":"2004","unstructured":"Adam B, Calikoglu E (2004) Serum interleukin-6, procalcitonin and C-reactive protien levels in subjects with active Beh\u00e7et\u2019s disease. J Eur Acad Dermatol Venereol 18(3):318\u2013320. https:\/\/doi.org\/10.1111\/j.1468-3083.2004.00907.x","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02805-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-023-02805-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02805-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T15:32:28Z","timestamp":1739460748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-023-02805-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":14,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["2805"],"URL":"https:\/\/doi.org\/10.1007\/s00403-023-02805-0","relation":{},"ISSN":["1432-069X"],"issn-type":[{"type":"electronic","value":"1432-069X"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"assertion":[{"value":"5 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by an ethics committee of Universty of Health Sciences, D\u0131\u015fkap\u0131 Y\u0131ld\u0131r\u0131m Beyaz\u0131t Training and Research Hospital,Ankara, Turkey (16.01.2017-34\/16).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"76"}}